Investment Focus Actively seeking European life science ventures across pharma, biotech, medtech, diagnostics and digital health provides a solid pipeline for strategic partnerships, co-investments, and portfolio synergies with growth-stage startups and clinical development programs.

Funding Momentum Recent fund close and large co-led rounds signal readiness to deploy capital, creating opportunities to engage in deal sourcing, co-investment talks, and co-financing of next-round financings with Hadean Ventures.

Nordic Presence Operations in Oslo and Stockholm with Nordic roots hint at strong regional focus and potential collaborations with European and Nordic biotech clusters seeking regional expertise, market access, and local regulatory navigation support.

Portfolio Growth Active investments in Actithera, Step Pharma, Alex Therapeutics, TargED Biopharmaceuticals and RibbonBiolabs illustrate appetite for diverse modalities and may create cross-sell opportunities in platform technologies, clinical development, and digital health solutions.

Market Positioning As a mid-sized venture principal with a revenue range in the low millions, Hadean Ventures presents partnership and advisory opportunities for early-stage to growth-stage startups seeking strategic investors, mentoring, and access to European and Nordic markets.